Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent

Registos relacionados

• Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis
  Por: Cundari, Giulia, et al.
  Publicado em: (2020)
• TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
  Por: Yamrozik, June A, et al.
  Publicado em: (2009)
• Left Ventricular Infarct Size Assessed with 0.1 mmol/kg Gadobenate Dimeglumine (Gd-BOPTA) Correlates with 0.2 mmol/kg of Gadopentetate Dimeglumine (Gd-DTPA)
  Por: Tumkosit, Monravee, et al.
  Publicado em: (2009)
• Quantitative assessment of diffuse myocardial fibrosis in II-type diabetes mellitus patients using T1 mapping technique: preliminary data
  Por: Galea, Nicola, et al.
  Publicado em: (2016)
• Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
  Por: Clauser, Paola, et al.
  Publicado em: (2018)